Pediatric and Adult Registry for Patients With ARThrogryposis

NCT05673265 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2023-01-06

No results posted yet for this study

Summary

The aim of the study is Epidemiological Evaluation of a single-centre national cohort of patients with Arthrogryposis multiplex congenita (AMC)

Conditions

  • Arthrogryposis Multiplex Congenita (AMC)

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Klaus DIETERICH, MD, PhD · Univ. Grenoble Alpes Inserm U1209 IAB CHU Grenoble Alpes

Eligibility

Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2023-07-01
Completion
2023-07-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05673265 on ClinicalTrials.gov